LMO7 Antikörper (AA 165-1560) (APC)
Kurzübersicht für LMO7 Antikörper (AA 165-1560) (APC) (ABIN8006037)
Target
Alle LMO7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 165-1560
-
Verwendungszweck
- Anti-LMO7 Antibody APC Conjugated
-
Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human LMO7 recombinant protein (Position: R165-R1560).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- LMO7 (LIM Domain 7 (LMO7))
-
Andere Bezeichnung
- LMO7
-
Hintergrund
-
Background: LIM domain only protein 7 is a protein that in humans is encoded by the LMO7 gene. This gene encodes a protein containing a calponin homology (CH) domain, a PDZ domain, and a LIM domain, and may be involved in protein-protein interactions. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene, however, the full-length nature of some variants is not known.
Gene Full Name: LIM domain 7
-
Gen-ID
- 4008
-
UniProt
- Q8WWI1
Target
-